Tissue engineering and regenerative medicine
2022 Activity indicators
- 1 public competitive project led by ISCIII.
- 1 intramural project (FIBioHRC).
- 3 private projects led.
- 4 clinical studies led.
- 1 competitive HR contract
- 53 publications.
- IF: 243.54
- Q1 publications: 16 (30 %).
- 9 supervised doctoral theses read
- 2 awards/recognitions
- Evaluators in international public agencies: 4 researchers.
- Evaluators in National Public Agencies: 2 researchers
- Member of Editorial Committees: 2 researchers
Milestones
- Launch of the AES21 multicentre competitive public health research project "Placental insufficiency secondary to gestational venous hypertension: influence of inflammatory status" (PI21/01244).
- Multicentre public project in the framework of the European response to the COVID-19 pandemic response.
- Doctoral thesis with international mention "Chronic venous insufficiency in the gestational period" and with 3 high impact publications in the framework of research on maternal-fetal welfare loss, publication of 2022 (PMID: 35207765).
- Dr. Julio Acero awarded "Honoris Causa" by the University of Athens (Greece).
- Scientific production of the group's priority lines funded by competitive public grants and patronage activities.
Bibliometrics
|
|
|
|
|
|
|
||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2018 | 11 | 33,07 | 3 | 7 | 64 | 1 | 9 | |||||||
| 2019 | 13 | 34,6 | 2,88 | 8 | 62 | 2 | 15 | |||||||
| 2020 | 24 | 66,94 | 3,04 | 14 | 58 | 0 | 0 | |||||||
| 2021 | 52 | 212,05 | 4,16 | 44 | 85 | 3 | 6 | |||||||
| 2022 | 53 | 243,54 | 4,6 | 45 | 85 | 2 | 4 | |||||||
| 153 | 590,2 | 3,54 | 118 | 77 | 8 | 5 |
* Only original articles, editorial material, guidelines and reviews.
